Pentylenetetrazol

Pentylenetetrazol

SCHEMBL20547995

C1CCc2nnnn2CC1.CC(O)CC(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
BLM P54132 1/20 0.59
HSD11B1 P28845 1/20 0.33
HSD11B2 P80365 1/20 0.33
POLB P06746 1/20 0.30
LMNA P02545 1/20 0.30
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentylenetetrazol SCHEMBL1571876 0.81 ALDH1A1 (0.69) MEN1KMT2AALDH1A1MAPTBLM
Pentylenetetrazol SCHEMBL22674 0.77 ALDH1A1 (1.00) MEN1KMT2AALDH1A1MAPTBLM
SCHEMBL3182039 0.77 ALDH1A1 (1.00) MEN1KMT2AALDH1A1MAPTBLM
Pentylenetetrazol SCHEMBL2260235 0.76 ALDH1A1 (0.76) MEN1KMT2AALDH1A1MAPTBLM
Pentylenetetrazol SCHEMBL10408117 0.75 ALDH1A1 (0.96) MEN1KMT2AALDH1A1MAPTBLM
Pentylenetetrazol SCHEMBL11463979 0.73 MAPT (0.69) MEN1KMT2AALDH1A1MAPTBLM
(R)-3-Hydroxybutanoate SCHEMBL1533862 0.64 SLC22A6 (0.56) MAPTLMNA
3-Hydroxybutyric Acid, (+/-)- SCHEMBL1881926 0.64 SLC22A6 (0.56) MAPTLMNA
3-Hydroxybutyric Acid, (+/-)- SCHEMBL1897117 0.64 SLC22A6 (0.56) MAPTLMNA
(R)-3-Hydroxybutanoate SCHEMBL29903959 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615084-A1 MEMBRANE ACTIVE MOLECULES Branequest, Inc. (US) 2020-03-04 EP disclosed
WO-2018200412-A1 MEMBRANE ACTIVE MOLECULES BraneQuest, Inc. (US) 2018-11-01 WO disclosed